New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AKR;MCD;MPEL;SYT;RHHBY;TSM;DST;AET;ATHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
December 17, 2014
10:52 EDTMCDAckman says can't comment on rumor of McDonald's stake
Subscribe for More Information
10:51 EDTAETLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
10:36 EDTATHNOptions with decreasing implied volatility
Subscribe for More Information
December 16, 2014
16:00 EDTMCDOptions Update; December 16, 2014
iPath S&P 500 VIX Short-Term Futures up 1.55 to 34.60. Option volume leaders: AAPL TSLA TWTR AMZN FB C GILD BAC NFLX AA MGM MCD according to Track Data.
15:37 EDTMPELChina to start crackdown on illicit funds to Macau, SCMP says
Subscribe for More Information
14:02 EDTMCDMcDonald's rises amid rumor of Ackman taking activist stake
Subscribe for More Information
12:56 EDTSYTSyngenta corn reportedly approved in China, Agri-Pulse says
Subscribe for More Information
10:55 EDTMCDMcDonald's spikes higher, levels to watch
Subscribe for More Information
10:48 EDTMCDRumor: McDonald's moving up amid activist investor speculation
Subscribe for More Information
10:34 EDTATHNOptions with decreasing implied volatility
Options with decreasing implied volatility: TLM LE CIEN LULU RH ATHN PAY
08:47 EDTRHHBYHemispherx Ampligen provides anti-tumor activity
Subscribe for More Information
05:46 EDTRHHBYRoche launches PCR molecular diagnostic system for point of care environment
Subscribe for More Information
December 15, 2014
11:32 EDTATHNathenahealth removed from short-term buy list at Deutsche Bank
10:23 EDTATHNOptions with decreasing implied volatility
Options with decreasing implied volatility: LE CIEN LULU PETM RH ATHN ADBE
08:40 EDTTSMCLSA technology analysts hold a luncheon meeting
Subscribe for More Information
05:24 EDTRHHBYExelixis announces Genentech files NDA for cobimetinib, vemurafenib combination
Exelixis (EXEL) announced its collaborator Genentech, a member of the Roche Group (RHHBY), has completed the filing of its New Drug Application, or NDA, with the FDA for cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib for previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation. Cobimetinib has received Fast Track designation by the FDA. Roche submitted a Marketing Authorization Application for the combination to the European Medicines Agency in September of this year. The NDA is based on data from the coBRIM trial, a phase 3 pivotal trial conducted by Genentech in 495 patients with BRAF V600 mutation-positive unresectable locally advanced or metastatic melanoma.
December 12, 2014
16:33 EDTMCDStocks finish week lower amid steep decline in oil prices
Subscribe for More Information
13:52 EDTAETLeerink healthcare services analyst holds an analyst/industry conference call
Subscribe for More Information
11:01 EDTATHNOptions with decreasing implied volatility
Subscribe for More Information
09:03 EDTAKRAcadia Realty Trust 3.4M share Spot Secondary priced at $31.75
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use